Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Winning Big

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.
Jan 5, 2011

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.

What to Watch for in 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Jan 2, 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

Winning Big

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.
Dec 2, 2010

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.

Buyers in Short Supply

Global pharmaceutical companies could have a problem getting rid of redundant facilities.
Nov 5, 2010

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

R&D Mash-ups

Changing demands in drug development lead to new service combinations and models.
Oct 12, 2010

Changing demands in drug development lead to new service combinations and models.

Buyers in Short Supply

Global pharmaceutical companies could have a problem getting rid of redundant facilities.
Oct 2, 2010

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

R&D Mash-ups

Changing demands in drug development lead to new service combinations and models.
Sep 2, 2010

Changing demands in drug development lead to new service combinations and models.

Be Careful for What You Wish

Rising labor costs in China may result in increased competition for higher value services.
Aug 4, 2010

Rising labor costs in China may result in increased competition for higher value services.

Slow Climb Back

The health of the contract-services industry is improving but the market is signaling tougher competition ahead. This article is part of the 2010 Outsourcing Resources special issue.
Aug 1, 2010

The health of the contract-services industry is improving but the market is signaling tougher competition ahead. This article is part of the 2010 Outsourcing Resources special issue.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here